Efficacy and Safety of a Second Adalimumab Treatment Cycle in Psoriasis Patients who Relapsed after Adalimumab Discontinuation or Dosage Reduction: A Double-Blind, Randomized, Placebo-Controlled Trial
暂无分享,去创建一个
M. Lebwohl | K. Gordon | M. Okun | Yihua Gu | J. Emer | R. Blum | Amir Larian | Robin R. Blum